Skip to content

A Randomized Controlled Trial of Respiratory Support Method for AIDS Patients With PCP Combined With ARF

Optimization of Respiratory Support of AIDS Patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024567
Enrollment
Unknown
Registered
2019-07-17
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired immunodeficicency syndrome and acute respiratory failure

Interventions

ARDS-net group:PEEPsettded by ARDS-net
PTP group:PEEP guided by the PTP

Sponsors

Beijing Ditan Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Obtaining informed consent; 2) Aged >= 18 years; 3) In accordance with the diagnosised criteria for AIDS in China AIDS diagnosis and treatment plan (third edition); 4) Meeting the criteria of the diagnostic criteria of acute respiratory distress syndrome (Berlin standard) for moderate to severe ARDS, but the time from onset to respiratory failure can be more than one week; 5) Invasive mechanical ventilation was given in the ICU for less than 8 hours.

Exclusion criteria

Exclusion criteria: 1) past medical history with chronic pulmonary diseases (COPD, asthma, bronchiectasis); 2) cardiogenic pulmonary edema (diagnosised by echocardiography or PICCO monitoring); 3) hemodynamic instability (SBP is lower than 90mmHg and tissue perfusion is insufficient after volume expansion and pressure booster support, or SBP > 180mmHg); 4) active bleeding exists;Acute coronary syndrome within one week, or presence of severe arrhythmia; 5) severe intracranial hypertension or neuromuscular lesions; 6) pregnancy; 7) patients with esophageal and gastric fundus lesions or surgery; 8) contraindications to respiratory mechanics; 9) pneumothorax, subcutaneous emphysema and obvious pulmonary bullae were present.

Design outcomes

Primary

MeasureTime frame
PaO2/FiO2 ratio;

Countries

China

Contacts

Public ContactAng Li

Beijing Ditan Hospital Affiliated to Capital Medical University

dtyyicu@ccmu.edu.cn+86 13910221530

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026